Next Issue
Previous Issue

Table of Contents

Pharmaceuticals, Volume 6, Issue 4 (April 2013), Pages 440-578

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-9
p. 440-468
by , ,  and
Pharmaceuticals 2013, 6(4), 440-468; doi:10.3390/ph6040440
Received: 24 January 2013; in revised form: 27 February 2013 / Accepted: 13 March 2013 / Published: 25 March 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (679 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 469-479
by , ,  and
Pharmaceuticals 2013, 6(4), 469-479; doi:10.3390/ph6040469
Received: 25 December 2012; in revised form: 23 February 2013 / Accepted: 15 March 2013 / Published: 26 March 2013
Show/Hide Abstract | PDF Full-text (212 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue NMDA Receptor Antagonists for Treatment of CNS Disorders)
p. 480-499
by  and
Pharmaceuticals 2013, 6(4), 480-499; doi:10.3390/ph6040480
Received: 31 January 2013; in revised form: 27 March 2013 / Accepted: 27 March 2013 / Published: 3 April 2013
Show/Hide Abstract | PDF Full-text (237 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue NMDA Receptor Antagonists for Treatment of CNS Disorders)
p. 500-509
by  and
Pharmaceuticals 2013, 6(4), 500-509; doi:10.3390/ph6040500
Received: 6 March 2013; in revised form: 20 March 2013 / Accepted: 1 April 2013 / Published: 8 April 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (939 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue GPCR Based Drug Discovery)
p. 510-521
by , ,  and
Pharmaceuticals 2013, 6(4), 510-521; doi:10.3390/ph6040510
Received: 31 December 2012; in revised form: 19 March 2013 / Accepted: 27 March 2013 / Published: 10 April 2013
Show/Hide Abstract | PDF Full-text (622 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 522-535
by
Pharmaceuticals 2013, 6(4), 522-535; doi:10.3390/ph6040522
Received: 27 December 2012; in revised form: 28 March 2013 / Accepted: 2 April 2013 / Published: 11 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (270 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 536-545
by , , , ,  and
Pharmaceuticals 2013, 6(4), 536-545; doi:10.3390/ph6040536
Received: 25 January 2013; in revised form: 9 April 2013 / Accepted: 9 April 2013 / Published: 12 April 2013
Show/Hide Abstract | PDF Full-text (1046 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue NMDA Receptor Antagonists for Treatment of CNS Disorders)
abstract graphic
p. 546-556
by , , ,  and
Pharmaceuticals 2013, 6(4), 546-556; doi:10.3390/ph6040546
Received: 4 March 2013; in revised form: 26 March 2013 / Accepted: 1 April 2013 / Published: 12 April 2013
Show/Hide Abstract | PDF Full-text (517 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Purine and Its Derivatives)
p. 557-578
by  and
Pharmaceuticals 2013, 6(4), 557-578; doi:10.3390/ph6040557
Received: 31 January 2013; in revised form: 26 February 2013 / Accepted: 7 April 2013 / Published: 17 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (485 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
Select/unselect all
Displaying article 1-9
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert